Pharma-Bio Serv, Inc. (PBSV) Analysts See $-0.01 EPS; Zoe's Kitchen, Inc. (ZOES) Had 2 Bullish Analysts

June 8, 2018 - By Jonathan Benavides

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Logo

Analysts expect Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) to report $-0.01 EPS on June, 13.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.01 EPS. It closed at $0.64 lastly. It is down 0.00% since June 8, 2017 and is . It has underperformed by 12.57% the S&P500.

Among 10 analysts covering Zoe’s Kitchen (NYSE:ZOES), 2 have Buy rating, 2 Sell and 6 Hold. Therefore 20% are positive. Zoe’s Kitchen has $50 highest and $12.0 lowest target. $19.50’s average target is 110.13% above currents $9.28 stock price. Zoe’s Kitchen had 44 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Thursday, August 17 by Telsey Advisory Group. The company was downgraded on Friday, May 25 by Piper Jaffray. As per Thursday, August 17, the company rating was maintained by Jefferies. Robert W. Baird maintained the shares of ZOES in report on Monday, September 18 with “Hold” rating. The stock has “Hold” rating by Deutsche Bank on Tuesday, August 23. The firm has “Buy” rating by Maxim Group given on Wednesday, August 19. The rating was maintained by Robert W. Baird with “Hold” on Tuesday, January 2. Jefferies upgraded the stock to “Buy” rating in Friday, November 10 report. The stock of Zoe's Kitchen, Inc. (NYSE:ZOES) has “Underperform” rating given on Friday, February 26 by Credit Suisse. The company was maintained on Sunday, August 30 by William Blair. See Zoe's Kitchen, Inc. (NYSE:ZOES) latest ratings:

25/05/2018 Broker: Piper Jaffray Rating: Sell Downgrade
25/05/2018 Broker: Maxim Group Old Rating: Buy New Rating: Hold Old Target: $20 Downgrade
25/05/2018 Broker: William Blair Rating: Hold Downgrade
22/02/2018 Broker: Jefferies Rating: Buy New Target: $17.0 Maintain
02/01/2018 Broker: Robert W. Baird Rating: Hold New Target: $15.0 Maintain
22/12/2017 Broker: Jefferies Rating: Buy New Target: $20.0 Maintain

Pharma-Bio Serv, Inc., a compliance and technology transfer services consulting company, provides compliance consulting services to the pharmaceutical, biotechnology, medical device, and chemical manufacturing companies in Puerto Rico, the United States, Europe, and Brazil. The company has market cap of $14.76 million. The companyÂ’s technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. It currently has negative earnings. It also provides microbiological testing services and chemical testing services through its laboratory; and technical trainings/seminars.

Investors sentiment increased to 1 in Q1 2018. Its up 0.38, from 0.62 in 2017Q4. It improved, as 11 investors sold Zoe's Kitchen, Inc. shares while 26 reduced holdings. 14 funds opened positions while 23 raised stakes. 17.73 million shares or 4.48% more from 16.97 million shares in 2017Q4 were reported. Salem Invest Counselors holds 0% or 200 shares in its portfolio. 52 are owned by Envestnet Asset. The Illinois-based Northern Tru Corporation has invested 0% in Zoe's Kitchen, Inc. (NYSE:ZOES). 3,769 were reported by Quantbot Tech L P. Waddell & Reed Incorporated holds 0% or 76,900 shares in its portfolio. Sib stated it has 190 shares. Renaissance Technology Limited Com invested in 0.01% or 438,300 shares. Macquarie Gp accumulated 66,356 shares. Robertson Opportunity Llc has invested 2.15% of its portfolio in Zoe's Kitchen, Inc. (NYSE:ZOES). State Street Corp has invested 0% of its portfolio in Zoe's Kitchen, Inc. (NYSE:ZOES). New York-based Jpmorgan Chase And has invested 0.01% in Zoe's Kitchen, Inc. (NYSE:ZOES). Tradewinds Limited Liability Company reported 0% of its portfolio in Zoe's Kitchen, Inc. (NYSE:ZOES). Blue Bell Private Wealth Mngmt Limited Liability Co has invested 0% of its portfolio in Zoe's Kitchen, Inc. (NYSE:ZOES). 545,448 were reported by Hhr Asset Limited Liability Corp. Legal & General Group Incorporated Public Ltd Co owns 0% invested in Zoe's Kitchen, Inc. (NYSE:ZOES) for 3,337 shares.

Zoe's Kitchen, Inc., through its subsidiaries, develops and operates a chain of fast-casual restaurants. The company has market cap of $181.92 million. It operates a range of restaurant formats, including in-line, end-cap, and free-standing restaurants. It currently has negative earnings. As of May 25, 2017, the firm operated 219 owned and franchised restaurants in 20 states of the United States.

Since February 22, 2018, it had 1 insider buy, and 0 selling transactions for $19.37 million activity. Misada Capital Flagship Fund LP had bought 1.35 million shares worth $19.37 million.

The stock decreased 5.21% or $0.51 during the last trading session, reaching $9.28. About 713,053 shares traded or 23.61% up from the average. Zoe's Kitchen, Inc. (NYSE:ZOES) has declined 46.60% since June 8, 2017 and is downtrending. It has underperformed by 59.17% the S&P500. Some Historical ZOES News: ; 26/04/2018 – Emerald Mutual Advisers Trust Buys 2.2% of Zoe’s Kitchen; 21/04/2018 – DJ Zoe’s Kitchen Inc, Inst Holders, 1Q 2018 (ZOES); 28/03/2018 Zoe’s Kitchen Closes Below 50-Day Moving Average: Technicals; 24/05/2018 – ZOE’S KITCHEN INC SEES FY 2018 RESTAURANT CONTRIBUTION MARGIN BETWEEN 16.0% AND 17.0%; 24/05/2018 – Zoe’s Kitchen 1Q Rev $102.1M; 24/05/2018 – ZOE’S KITCHEN INC – STRATEGIC ACTIONS WILL LIKELY HAVE A MATERIAL IMPACT TO FINANCIAL STATEMENTS IN FISCAL YEAR 2018; 24/05/2018 – ZOE’S KITCHEN INC – FULL FINANCIAL IMPACT OF STRATEGIC ACTIONS IS NOT CURRENTLY INCLUDED IN COMPANY’S REVISED OUTLOOK; 24/05/2018 – Zoe’s Kitchen Cuts 2018 View To Rev $345M-$352M; 24/05/2018 – Zoe’s Kitchen: Financial Impact of Strategic Actions Hasn’t Been Determined and Isn’t Currently Included in Co’s Revised Outlook; 24/05/2018 – Zoe’s Kitchen: Company Is Initiating Certain Strategic Actions to Improve Ops and Fincl Performance

Zoe's Kitchen, Inc. (NYSE:ZOES) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts